Mechanisms of Intravenous Immunoglobulin Action in Immune Thrombocytopenic Purpura
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 66 (4) , 403-410
- https://doi.org/10.1016/j.humimm.2005.01.029
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodiesBritish Journal of Haematology, 1997
- Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]Blood, 1996
- Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation- dependent antigensBlood, 1993
- Experience with intravenous immunoglobulin in myasthenia gravisClinical Immunology and Immunopathology, 1989
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985
- Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpuraBlood, 1984
- Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpuraBlood, 1983
- HIGH-DOSE INTRAVENOUS IgG IN ADULTS WITH AUTOIMMUNE THROMBOCYTOPENIAThe Lancet, 1983
- Specificity of autoantibodies in autoimmune thrombocytopeniaBlood, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981